Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Otorhinolaryngology

  Free Subscription


Articles published in BMJ

Retrieve available abstracts of 22 articles:
HTML format



Single Articles


    June 2025
  1. MAHASE E
    How can I support my deaf or hard of hearing colleague?
    BMJ. 2025;389:r1030.
    PubMed    


    April 2025

  2. Medical news in brief: Trump shuts STI lab, warning over doctor fatigue, NHS accused of failing deaf people, and other stories.
    BMJ. 2025;389:r838.
    PubMed    


  3. SHEPHERD A
    Art, language, and living with deafness.
    BMJ. 2025;389:r853.
    PubMed    


  4. IACOBUCCI G
    Senior paediatrician will lead review of "unacceptable" hearing test failures.
    BMJ. 2025;389:r776.
    PubMed    


  5. XIE WH, Xiao WW, Chang H, Xu MJ, et al
    Four cycles of docetaxel plus cisplatin as neoadjuvant chemotherapy followed by concurrent chemoradiotherapy in stage N2-3 nasopharyngeal carcinoma: phase 3 multicentre randomised controlled trial.
    BMJ. 2025;389:e081557.
    PubMed     Abstract available


  6. XU M, Yang S, Cui E, Wang Z, et al
    Induction chemotherapy for nasopharyngeal carcinoma.
    BMJ. 2025;389:r652.
    PubMed    


    March 2025
  7. TANNE JH
    Trump's CDC nominee abruptly withdrawn before committee hearing.
    BMJ. 2025;388:r527.
    PubMed    


    November 2024
  8. WEBSTER G
    d/Deaf students: feeling heard in medical school.
    BMJ. 2024;387:q2595.
    PubMed    


    October 2024
  9. AHMAD A
    Hearing stories of domestic abuse of female NHS doctors paves way to receive stories of women survivors of violence with empathy.
    BMJ. 2024;387:q2190.
    PubMed    


    July 2024
  10. HOUGH K, Tsimpida D, Boswell S, Satchwell C, et al
    Deaf awareness strategies in healthcare.
    BMJ. 2024;386:q1438.
    PubMed    


    June 2024

  11. Nab-paclitaxel, cisplatin, and capecitabine versus cisplatin and gemcitabine as first line chemotherapy in patients with recurrent or metastatic nasopharyngeal carcinoma: randomised phase 3 clinical trial.
    BMJ. 2024;385:q1381.
    PubMed    


  12. LIU GY, Ye YF, Jiang YF, Chen GJ, et al
    Nab-paclitaxel, cisplatin, and capecitabine versus cisplatin and gemcitabine as first line chemotherapy in patients with recurrent or metastatic nasopharyngeal carcinoma: randomised phase 3 clinical trial.
    BMJ. 2024;385:e077890.
    PubMed     Abstract available


  13. DYER O
    Fauci is defiant as congressional hearing into covid origins fails to produce smoking gun.
    BMJ. 2024;385:q1231.
    PubMed    


    May 2024
  14. IBRAHIM Y, Young K, Gane J, Judd O, et al
    A woman with recurrent spontaneous throat swelling.
    BMJ. 2024;385:e078481.
    PubMed    


  15. SAUL H, Cassidy S, Swaithes L, Carrie S, et al
    Surgery is better than nasal sprays for people with severely blocked airways caused by septal deviation.
    BMJ. 2024;385:q876.
    PubMed     Abstract available


    April 2024
  16. HOLLORAN S
    Doing more for patients with hearing loss.
    BMJ. 2024;385:q894.
    PubMed    


  17. NADARAJAH S
    Haytox: what is the evidence for a Botox spray for hay fever?
    BMJ. 2024;385:q623.
    PubMed    


    March 2024
  18. WILKINSON E
    AI app that can diagnose acute otitis media may cut antibiotic use, say researchers.
    BMJ. 2024;384:q572.
    PubMed    


  19. FRANKLIN BD, Bartel R, Howitt P
    Avoiding harm through hearing our patients.
    BMJ. 2024;384:q532.
    PubMed    


  20. BRADLEY P, Deane J, O'Hara J, Kennedy M, et al
    Teledentistry may help in detecting oral cancers in current GP and dentist shortages.
    BMJ. 2024;384:q512.
    PubMed    


    February 2024
  21. ABIOYE K
    The importance of British Sign Language.
    BMJ. 2024;384:p2615.
    PubMed    


  22. DURNO J
    The NHS is failing deaf people.
    BMJ. 2024;384:q480.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Otorhinolaryngology is free of charge.